AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$312,573
-0.67%
Shares
Shares Volume: 15,907 Shares
Average Share Price: $19.65
INSIDER
Adjuvant Global Health Technology Fund, L.P.
10% Owner
reported on Jan 18 2024
traded on Jan 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT
2,373,500
PURCHASES/SALES 1Y0 / 14
P/S VALUE RATION/A
AVERAGE SALE VALUE$283,381.31
INSIDER PREVIOUS TRADES
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS
with at least one purchase / sale
0 / 4
PURCHASES/SALES 1Y2 / 33
P/S VALUE RATIO2.533
AVERAGE SALE VALUE$192,080.35
COMPANY PREVIOUS TRADES
Get Feature Updates
Subscribe to our newsletter and receive the latest updates. You will get pre-access to new features